The situation has become very serious due to the fast-growing corona infection in the country. However, the government is taking all possible steps to deal with it. Given this, vaccination of the people above 18 years of age is going to start in the country from May 1. At the same time, the Drugs Controller General of India, DGCI has approved the emergency use of Virafin of Zydus Cadila for the treatment of corona in adults.
Drugs Controller General of India (DGCI) approves emergency use for Zydus Cadila's Pegylated Interferon alpha-2b, ‘Virafin’ for treating moderate #COVID19 infection in adults. pic.twitter.com/bXBvHZaIBp
— ANI (@ANI) April 23, 2021
Let me tell you that Zydus Cadila is a pharmaceutical manufacturer based in Ahmedabad, Gujarat. The company states that the emergency use of Pegylated Interferon alpha-2b, 'Virafin' in corona-infected adults, will help a lot. Zydus Cadila said that Virafin medicines would be provided to hospitals. It is an antiviral drug that will make the treatment of corona more convenient.